Amid treaty talks to create equitable access to medical products during pandemics, the European Union has proposed pricing language that may put the pharmaceutical industry and advocacy groups on a collision course.
In a proposal submitted earlier this week, the European Union suggested middle-income countries could pay so-called tiered pricing for drugs, vaccines, and other medical products needed during a pandemic. Tiered pricing refers to a range of prices based on different variables, and in this case would involve a country’s population, epidemiological situation, income level, and ability to pay.
